The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Figure S1: jde70280-sup-0001-FigureS1.docx. Additional clinical images demonstrating changes in scale thickness. Representative close-up images of the lower leg at baseline (0 weeks) and after 44 weeks of lebrikizumab treatment. Although image resolution is limited, a reduction in the thickness of lamellar scales can be appreciated while the overall polygonal pattern of scaling is preserved. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Ishitsuka et al. (Sun,) studied this question.